TRIATEC Side Effects

6836531-4 | Anaemia, Diarrhoea, Hyperkalaemia, Lactic Acidosis, Renal Failure Acute, Vomiting, White Blood Cell Count Increased
on Jun 28, 2010 Female patient from FRANCE , 83 years of age, was treated with Triatec (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, diarrhoea, hyperkalaemia, lactic acidosis, renal failure acute, vomiting, white blood cell count increased. Triatec dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), PLAVIX (View Plavix Review and Plavix Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ). Patient was hospitalized.

6577066-6 | Toxic Skin Eruption
Patient was taking Triatec (View Usage). Patient had the following side effects: toxic skin eruption on Feb 09, 2010 from FRANCE Additional patient health information: Female patient , 81 years of age, . Triatec dosage: . During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), PREVISCAN (View Previscan Review and Previscan Label ), LANTUS (View Lantus Review and Lantus Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), DIFFU K (View Diffu K Review and Diffu K Label ). Patient was hospitalized.

6479976-7 | Cardiac Failure, Clostridium Difficile Colitis, Condition Aggravated, Dehydration, Hyponatraemia, Renal Failure Acute, Vomiting
Adverse event was reported on Nov 27, 2009 by a Female patient taking Triatec (View Usage) (Dosage: ) was diagnosed with atrial fibrillation (What is atrial fibrillation?), erysipelas, gastritis and. Location: FRANCE , 78 years of age, After Triatec was administered, patient had the following side effects: cardiac failure, clostridium difficile colitis, condition aggravated, dehydration, hyponatraemia, renal failure acute, vomiting. During the same period patient was treated with CORDARONE (View Cordarone Review and Cordarone Label ), LASILIX (View Lasilix Review and Lasilix Label ), SPECIAFOLDINE (Dose:1 Unit(s)) (View Speciafoldine Review and Speciafoldine Label ), LANTUS (View Lantus Review and Lantus Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), NEXIUM /UNK/ (View Nexium /unk/ Review and Nexium /unk/ Label ), PREVISCAN (View Previscan Review and Previscan Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ).

5355109-5 | Anorexia, Asthenia, Blood Creatinine Increased, Blood Urea Increased, Dehydration, Gastroenteritis, Hyperkalaemia, Renal Failure Acute
on Jun 05, 2007 Male patient from FRANCE , 76 years of age, weighting 119.0 lb, was treated with Triatec (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, asthenia, blood creatinine increased, blood urea increased, dehydration, gastroenteritis (What is gastroenteritis?), hyperkalaemia, renal failure acute. Triatec dosage: 1 Df, Qd. During the same period patient was treated with RIVOTRIL (3 Df Daily) (View Rivotril Review and Rivotril Label ), TAREG (80 Mg, Qd) (View Tareg Review and Tareg Label ), MIXTARD HUMAN 70/30 (View Mixtard Human 70/30 Review and Mixtard Human 70/30 Label ), BUFLOMEDIL HYDROCHLORIDE (600 Mg Daily) (View Buflomedil Hydrochloride Review and Buflomedil Hydrochloride Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ). Patient was hospitalized.


5331386-1 | Anaemia, Oesophagitis
on May 14, 2007 Female patient from FRANCE , weighting 88.18 lb, was diagnosed with coronary angioplasty, coronary arterial stent insertion and was treated with Triatec (View Usage). Patient had the following side effects: anaemia, oesophagitis. Triatec dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ), FLIXOTIDE DISKUS (View Flixotide Diskus Review and Flixotide Diskus Label ), SEREVENT (Unk) (View Serevent Review and Serevent Label ), MOVICOL (Unk) (View Movicol Review and Movicol Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ). Patient was hospitalized.

5166485-0 | Abdominal Distension, Abdominal Pain Upper, Anaemia, Ascites, Cholecystitis, Coagulation Factor V Level Decreased, Condition Aggravated, Cyanosis, Dyspnoea
Patient was taking Triatec (View Usage). After Triatec was administered, patient had the following side effects: abdominal distension, abdominal pain upper, anaemia, ascites, cholecystitis, coagulation factor v level decreased, condition aggravated, cyanosis, dyspnoea on Nov 24, 2006 from FRANCE Additional patient health information: Male patient , 75 years of age, was diagnosed with fracture (What is fracture?) and. Triatec dosage: 2.5 Mg, Qd. During the same period patient was treated with METFORMIN HCL (850 Mg, Tid) (View Metformin Hcl Review and Metformin Hcl Label ), DIAMICRON (80 Mg, Tid) (View Diamicron Review and Diamicron Label ), ACARBOSE (100 Mg, Tid) (View Acarbose Review and Acarbose Label ), TADENAN (50 Mg, Bid) (View Tadenan Review and Tadenan Label ), DIFFU K (1 Df, Tid) (View Diffu K Review and Diffu K Label ), EFFERALGAN (1 Df, Tid) (View Efferalgan Review and Efferalgan Label ), OGAST (View Ogast Review and Ogast Label ), VOLTAREN (50 Mg, Bid) (View Voltaren Review and Voltaren Label ). Patient was hospitalized.

5158825-3 | Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Hypothyroidism, Myalgia
Adverse event was reported on Sep 18, 2006 by a Male patient taking Triatec (View Usage) (Dosage: ) was diagnosed with myocardial ischaemia, stent placement, hypercholesterolaemia and. Location: FRANCE , weighting 147.7 lb, Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, blood lactate dehydrogenase increased, hypothyroidism, myalgia. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), TAHOR (View Tahor Review and Tahor Label ), EZETROL (View Ezetrol Review and Ezetrol Label ).

5066389-8 | Haemodialysis, Renal Failure Acute
on Jul 27, 2006 Male patient from , 55 years of age, was treated with Triatec (View Usage). Patient had the following side effects: haemodialysis, renal failure acute. Triatec dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), DOGOXINE (View Dogoxine Review and Dogoxine Label ), TEGELINE (View Tegeline Review and Tegeline Label ).

5022117-3 | Hyperkalaemia, Renal Failure Acute, Syncope
on May 30, 2006 Female patient from , 69 years of age, weighting 149.9 lb, was diagnosed with hypertension, ischaemic cardiomyopathy, myocardial ischaemia and was treated with Triatec (View Usage). After Triatec was administered, patient had the following side effects: hyperkalaemia, renal failure acute, syncope. Triatec dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), DIFFU K (View Diffu K Review and Diffu K Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), MOPRAL (View Mopral Review and Mopral Label ), LASILIX (View Lasilix Review and Lasilix Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

5002814-6 | Lichenoid Keratosis, Pruritus, Rash Maculo-papular
Patient was taking Triatec (View Usage). Patient experienced the following unwanted or unexpected effects: lichenoid keratosis, pruritus, rash maculo-papular on May 02, 2006 from Additional patient health information: Male patient , 72 years of age, weighting 154.3 lb, . Triatec dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), APROVEL (View Aprovel Review and Aprovel Label ), TAHOR (View Tahor Review and Tahor Label ), DILRENE (View Dilrene Review and Dilrene Label ). Patient was hospitalized.

4956356-4 | Bone Disorder, Bone Scan Abnormal, Excessive Granulation Tissue, Osteonecrosis, Tooth Abscess, Tooth Disorder
Adverse event was reported on Feb 23, 2006 by a Female patient taking Triatec (View Usage) (Dosage: ) was diagnosed with metastases to bone and. Location: ITALY , 62 years of age, Patient had the following side effects: bone disorder, bone scan abnormal, excessive granulation tissue, osteonecrosis (What is osteonecrosis?), tooth abscess, tooth disorder (What is tooth disorder?). During the same period patient was treated with ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ), AREDIA (90 Mg, Qmo) (View Aredia Review and Aredia Label ), CLASTEON (100 Mg, Unk) (View Clasteon Review and Clasteon Label ), VINORELBINE (1 G Every 8/21 Days) (View Vinorelbine Review and Vinorelbine Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), SOLOSA (View Solosa Review and Solosa Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), FARLUTAL (View Farlutal Review and Farlutal Label ).

4784353-0 | Bradypnoea, Dehydration, Overdose, Pulmonary Congestion, Renal Failure Acute, Somnolence
on Sep 20, 2005 Female patient from , 66 years of age, weighting 134.5 lb, was treated with Triatec (View Usage). After Triatec was administered, patient had the following side effects: bradypnoea, dehydration, overdose, pulmonary congestion, renal failure acute, somnolence. Triatec dosage: Dose Unit: Units. During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), MORPHINE (View Morphine Review and Morphine Label ), NITROGLYCERIN (Dose Unit: Units) (View Nitroglycerin Review and Nitroglycerin Label ), KARDEGIC (Dose Unit: Units) (View Kardegic Review and Kardegic Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), INSULATARD NPH HUMAN (View Insulatard Nph Human Review and Insulatard Nph Human Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.

4776827-3 | Arteriospasm Coronary, Myocardial Infarction
on Mar 10, 2005 Male patient from FRANCE , 68 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Triatec (View Usage). Patient experienced the following unwanted or unexpected effects: arteriospasm coronary, myocardial infarction. Triatec dosage: Dose: Unk. During the same period patient was treated with LASILIX (Dose: Unk) (View Lasilix Review and Lasilix Label ), ZOLADEX (View Zoladex Review and Zoladex Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FONZYLANE (View Fonzylane Review and Fonzylane Label ), XATRAL (View Xatral Review and Xatral Label ), ELISOR (View Elisor Review and Elisor Label ), KREDEX (View Kredex Review and Kredex Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

4683681-7 | Acidosis, Blood Potassium Increased, Blood Sodium Increased, Dehydration, Depressed Level Of Consciousness, Inflammation, Renal Failure Acute
Patient was taking Triatec (View Usage). Patient had the following side effects: acidosis, blood potassium increased, blood sodium increased, dehydration, depressed level of consciousness, inflammation, renal failure acute on May 27, 2005 from Additional patient health information: Female patient , 82 years of age, weighting 141.1 lb, was diagnosed with essential hypertension and. Triatec dosage: . During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ), LEPTICUR (View Lepticur Review and Lepticur Label ), SOLIAN (View Solian Review and Solian Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), VASTEN (View Vasten Review and Vasten Label ). Patient was hospitalized.

4675624-7 | Eosinophilia, Exanthem, Hypersensitivity, Pleural Effusion, Pyrexia, Rash Maculo-papular, Renal Failure Acute, Skin Exfoliation
Adverse event was reported on May 17, 2005 by a Male patient taking Triatec (View Usage) (Dosage: ) was diagnosed with antibacterial prophylaxis and. Location: , 64 years of age, After Triatec was administered, patient had the following side effects: eosinophilia, exanthem, hypersensitivity, pleural effusion, pyrexia, rash maculo-papular, renal failure acute, skin exfoliation. During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), GENTAMICIN SULFATE (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ), SINTROM (View Sintrom Review and Sintrom Label ), CLAMOXYL (View Clamoxyl Review and Clamoxyl Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), TEMESTA (View Temesta Review and Temesta Label ), MOPRAL (View Mopral Review and Mopral Label ). Patient was hospitalized.

4653323-5 | Blood Creatinine Increased, Haematuria, Post Procedural Complication, Renal Impairment
on Oct 11, 2004 Male patient from , 53 years of age, weighting 141.1 lb, was treated with Triatec (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, haematuria, post procedural complication, renal impairment. Triatec dosage: . During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ). Patient was hospitalized.

4614796-7 | Arteriospasm Coronary, Myocardial Infarction
on Mar 10, 2005 Male patient from , 68 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Triatec (View Usage). Patient had the following side effects: arteriospasm coronary, myocardial infarction. Triatec dosage: Dose: Unk. During the same period patient was treated with LASILIX (Dose: Unk) (View Lasilix Review and Lasilix Label ), ZOLADEX (View Zoladex Review and Zoladex Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FONZYLANE (View Fonzylane Review and Fonzylane Label ), XATRAL (View Xatral Review and Xatral Label ), ELISOR (View Elisor Review and Elisor Label ), KREDEX (View Kredex Review and Kredex Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

4582566-4 | Hyperkalaemia, Renal Failure
Patient was taking Triatec (View Usage). After Triatec was administered, patient had the following side effects: hyperkalaemia, renal failure on Feb 02, 2005 from Additional patient health information: Male patient , 74 years of age, . Triatec dosage: . During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), PRAZOSIN HCL (View Prazosin Hcl Review and Prazosin Hcl Label ), TAHOR (View Tahor Review and Tahor Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

4558139-6 | Renal Failure Acute, Treatment Noncompliance
Adverse event was reported on Jan 13, 2005 by a Male patient taking Triatec (View Usage) (Dosage: ) was diagnosed with cardiac failure and. Location: , 91 years of age, Patient experienced the following unwanted or unexpected effects: renal failure acute, treatment noncompliance. During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ). Patient was hospitalized.